2020
DOI: 10.1172/jci.insight.137427
|View full text |Cite
|
Sign up to set email alerts
|

Comprehensive plasma proteomic profiling reveals biomarkers for active tuberculosis

Abstract: BACKGROUND. Tuberculosis (TB) kills more people than any other infection, and new diagnostic tests to identify active cases are required. We aimed to discover and verify novel markers for TB in nondepleted plasma. METHODS. We applied an optimized quantitative proteomics discovery methodology based on multidimensional and orthogonal liquid chromatographic separation combined with high-resolution mass spectrometry to study nondepleted plasma of 11 patients with active TB compared with 10 healthy controls. Priori… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

4
31
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
5
3
1

Relationship

0
9

Authors

Journals

citations
Cited by 45 publications
(35 citation statements)
references
References 69 publications
(117 reference statements)
4
31
0
Order By: Relevance
“…Interestingly, this has also been observed in another proteomics study. 7 Overall our analysis recapitulates previous findings and showcases the applicability of DIA and multi-protease digestion for robust analysis of clinical samples.…”
Section: Identification and Quantification Of Mtb Proteinssupporting
confidence: 85%
See 1 more Smart Citation
“…Interestingly, this has also been observed in another proteomics study. 7 Overall our analysis recapitulates previous findings and showcases the applicability of DIA and multi-protease digestion for robust analysis of clinical samples.…”
Section: Identification and Quantification Of Mtb Proteinssupporting
confidence: 85%
“…To mitigate issues in protein detection, numerous studies have successfully employed extensive off-line chromatographic fractionation, allowing for the injection of individual fractions of reduced complexity into the mass spectrometer. This approach has been highly successful to increase the number of proteins detectable in plasma, 6,7 albeit at the cost of a correspondingly dramatic increase in MS acquisition time to analyze dozens of fractions. Furthermore, the reliance on off-line fractionation introduces a low-throughput and cumbersome additional step in sample preparation that is not accessible to many labs.…”
Section: Introductionmentioning
confidence: 99%
“…However, the current use of blood-based available immunological tests including T-SPOT.TB (T-SPOT) and QuantiFERON-TB Gold In-Tube (QFT-GIT) was limited by their poor ability to reliably stratify ATB from LTBI especially in TB endemic areas (8,9). Recent advances have been developed in blood signatures including transcriptome (10), proteome (11), genome (12), metabolome (13), cytokines (14,15), and markers on immune cells (16,17) for identifying ATB, raising hopes for translation into available assays. However, due to the fact that the application of these emerging methods has not been verified with sufficient repetition and large sample size, the real diagnostic utility under actual clinical conditions remains unclear (18).…”
Section: Introductionmentioning
confidence: 99%
“…Multiple limitations registered by conventional tests of etiology hurdles to the timely diagnosis of disease and contribute to promote clinical progression as well as continued transmission. Recent advances in genomics (16,17), transcriptomics (18)(19)(20), proteomics (21)(22)(23), and metabolomics (24)(25)(26) have effectively facilitated the diagnosis of TB. But these emerging methods often require prohibitively complex equipment and operations, which hinder their promotion of clinical applications.…”
Section: Introductionmentioning
confidence: 99%